These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11906955)

  • 1. A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy.
    Doheny HC; Whittington MA; Jefferys JG; Patsalos PN
    Br J Pharmacol; 2002 Mar; 135(6):1425-34. PubMed ID: 11906955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on levetiracetam in epilepsy.
    Lyseng-Williamson KA
    CNS Drugs; 2011 Oct; 25(10):901-5. PubMed ID: 21936590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
    Leppik IE; Biton V; Sander JW; Wieser HG
    Epilepsia; 2003 Dec; 44(12):1585-7. PubMed ID: 14636332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
    Glien M; Brandt C; Potschka H; Löscher W
    Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model - a type II isobolographic analysis.
    Florek-Luszczki M; Wlaz A; Luszczki JJ
    Eur J Pharmacol; 2014 Jan; 723():410-8. PubMed ID: 24211788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Shih JJ; Whitlock JB; Chimato N; Vargas E; Karceski SC; Frank RD
    Epilepsy Behav; 2017 Apr; 69():186-222. PubMed ID: 28237319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
    Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM
    Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats.
    Löscher W; Reissmüller E; Ebert U
    Epilepsy Res; 2000 Jun; 40(1):63-77. PubMed ID: 10771259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.